Trials (2081)
Page 16 of 35.
- Effect of Repeated Administration of Liraglutide on Insulinogenic Indices
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Subcutaneous Injections of HRS9531 in Patients With Type 2 Diabetes Mellitus
- Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes
- A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
- Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data
- A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes
- Exenatide Once-weekly as a Treatment for Multiple System Atrophy
- A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects
- Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying
- RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
- Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes
- Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects
- Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
- The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes
- Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes
- Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea
- Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes
- EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
- Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
- A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
- A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy
- MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
- LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
- A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity
- Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
- An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder
- Exenatide Once Weekly for Smoking Cessation
- A Research Study Looking at New Protein-based Tablets in Healthy Male Participants
- Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
- Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis
- STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss
- Imaging in Semaglutide Study
- Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
- Semaglutide and Intestinal Iron Absorption
- Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity
- Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
- In-patient Study in Patients With Type 2 Diabetes Mellitus
- Liraglutide as add-on to Insulin in Type 1 Diabetes
- Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
- A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients
- A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)
- Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes
- Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin
- BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity
- INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)
- Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function
- The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes
- SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinson's Disease
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus
- Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes
- Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
- A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.
- 24-h Energy Expenditure and Anti-obesity Medication
- Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
- Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation
- Bariatric Surgery Combined With GLP-1 Receptor Agonists Study
- Research of Intensive Metabolic Intervention Before Pregnancy in PCOS
- Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea